[Form 4] Microchip Technology Inc Insider Trading Activity

Rhea-AI Filing Summary

Microchip Technology Inc. insider Richard J. Simoncic, listed as Chief Operating Officer, reported a sale of 2,000 shares of Microchip common stock on 08/22/2025 at a price of $69.14 per share. After the transaction he is reported to beneficially own 151,001 shares indirectly through a trust. The Form 4 was signed by an attorney-in-fact on 08/27/2025. No derivative transactions or additional remarks were disclosed in the filing.

Positive

• None.

Negative

• Insider sale of 2,000 shares by the COO on 08/22/2025 at $69.14 per share; could be perceived negatively by some investors

Insights

Corporate Governance Expert

TL;DR: A routine insider sale by the COO; scale appears modest relative to typical executive holdings.

The Form 4 discloses a single non-derivative sale of 2,000 common shares at $69.14, leaving 151,001 shares held indirectly in a trust. The filing shows the transaction was executed under the reporting persons control and reported by attorney-in-fact. There are no accompanying derivative transactions or plan details indicated, suggesting this was a one-off disposition rather than a scheduled plan filing. Governance implications are limited absent further context on timing or purpose.

Securities Analyst

TL;DR: Insider sale recorded; transaction size is small and unlikely to be materially informative for valuation.

The sale of 2,000 shares at $69.14 represents a modest liquidity event. Remaining indirect beneficial ownership of 151,001 shares is disclosed, which maintains meaningful economic exposure but does not indicate a change in control or pledge. No option exercises, grants, or derivative activity were reported. From a market-impact perspective, this single sale is routine and not clearly material to Microchips financial outlook based on the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simoncic Richard J

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER AZ 85224-6199

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF OPERATING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		G		2,000	D	$69.14	151,001	I	Shares held Indirectly, by Trust.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for MCHP disclose?

The Form 4 reports that COO Richard J. Simoncic sold 2,000 shares on 08/22/2025 at $69.14 and now beneficially owns 151,001 shares indirectly.

How many shares does Richard J. Simoncic own after the transaction?

The filing reports 151,001 shares beneficially owned following the reported transaction, held indirectly via a trust.

Were any derivative transactions reported in this Form 4 for MCHP?

No. The filing includes no derivative securities, option exercises, or convertible securities disclosures.

When was the transaction and when was the Form 4 signed?

The transaction date is 08/22/2025 and the form was signed by an attorney-in-fact on 08/27/2025.

Does the Form 4 indicate the sale was part of a 10b5-1 plan?

No box or remark in the provided content indicates the transaction was reported as made pursuant to a 10b5-1 plan.